In Re Taylor

484 F. App'x 540
Court of Appeals for the Federal Circuit·Decided June 14, 2012·No. 2012-1006·Unpublished

Opinion

LOURIE, Circuit Judge.

Appellants Jason Arthur Taylor, Rebecca Ann Zeltinger, and John G. Cosby, Jr., (collectively, “Taylor”) appeal from the decision of the Board of Patent Appeals and Interferences (“the Board”) affirming the rejections of all pending claims of U.S. Patent Application No. 11/429,507 (“the '507 Application”) as anticipated, obvious, and/or lacking adequate written description. See Ex parte Taylor, No.2010-009465, 2011 WL 1131356 (B.P.A.I. Mar. 28, 2011) (“Board, Decision"), reh’g denied, 2011 WL 2601873 (B.P.A.I. June 29, 2011). Because the Board correctly construed the pending claims of the '507 application and did not err in finding those claims unpatentable in view of the cited prior art, we affirm.

Background

The '507 Application discloses a cellulose-based dough that “can be used to form a variety of low-calorie foods.” '507 Application at 4, ¶ 13. Instead of flour, which contributes significantly to the caloric content of conventional baked goods, the disclosed dough contains a mixture of cellulose, hydrocolloids (such as methylcellu-lose, xanthan gum, and hemicellulose), and other ingredients. According to the written description of the '507 Application, the disclosed dough can be used to make a variety of low-calorie foods, such as doughnuts, breads, crackers, cakes, sauces, and flavored dips that are “nearly, though not completely, as savory and satisfying as their traditional, full-calorie counterparts.” Id. at 7, ¶ 21. The '507 Application defines “low-calorie” as “a >50% caloric reduction as compared to the traditional version of the food per unit weight.” Id. at 2, ¶ 3.

Taylor filed the '507 Application with 36 original claims on May 5, 2006. The examiner issued a non-final office action on August 5, 2008, and Taylor responded on December 6, 2008 by amending claims 1-15, canceling claims 16-36, and adding new claims 37-58. All of the pending claims except independent claim 58 depend, directly or indirectly, from independent claim 1. Claim 1 is representative and, as amended, reads as follows:

1. A mix for making low-calorie, palatable food or food components comprising by dry weight at least about 30% of fiber that is at least 50% cellulose, and an effective amount of hydrocolloids to help bind said mix to water.

J.A. 355 (emphases added). In addition, Taylor’s response included several proposed amendments to the specification cor *542 responding to the new and amended claims. See Suppl. App. 289, 294-300.

In a final office action dated March 23, 2009, the examiner rejected all of Taylor’s pending claims. In pertinent part, claims 1, 3-7, and 9-14 were rejected as anticipated under 35 U.S.C. § 102(b) by U.S. Patent 5,976,598 (“Akkaway”); claims 2, 8, 15, and 37-58 were rejected as obvious under 35 U.S.C. § 103(a) in view of Akkaway; claims 3, 37-43, 47-49, 51, 53, and 57 were rejected as lacking adequate written description under 35 U.S.C. § 112, ¶ 1; and claim 14 was rejected for lack of enablement under § 112, ¶ 1. The examiner also declined to enter most of Taylor’s proposed amendments to the specification on grounds that those amendments would introduce new matter.

The Board reversed the examiner’s en-ablement rejection as to claim 14 but affirmed the remaining rejections. In particular, the Board held that the terms “low-calorie” and “palatable” found in the preambles of independent claims 1 and 58 are non-limiting because they merely reflect intended uses or purposes without imposing any structural limitation on the claimed compositions. Board, Decision at 6-7. Thus, the Board concluded that the terms “at least about 30% of fiber that is at least 50% cellulose” and “an effective amount of hydrocolloids to help bind said mix to water” were the only limitations of claim 1 entitled to patentable weight. Id. at 7. On the merits, the Board found that (i) Akkaway discloses low-calorie flour replacement compositions comprising coated particulate cellulose capable of replacing all or part of a food’s starch component; (ii) Akkaway’s cellulose compositions can be mixed with 10% or more hydrocolloid bulking agents such as carboxymethylcel-lulose, arabinogalactan, xanthan gum, and methylcellulose; and (iii) Taylor’s specification discloses an exemplary dough containing only 3.8% hydrocolloid. Id. at 3-4. Based on those findings, the Board held that Akkaway anticipated claim 1, and the Board affirmed the examiner’s obviousness rejections on similar grounds. Id. at 7-9. Regarding the written description rejections, the Board held that Taylor had provided no evidence that one of skill in the art would have recognized the disputed claim limitations as explicitly or inherently supported in the '507 Application’s original disclosure. Id. at 11-12.

The Board denied Taylor’s request for rehearing, and Taylor timely appealed to this court. We have jurisdiction pursuant to 28 U.S.C. § 1295(a)(4)(A).

Discussion

We review the Board’s legal conclusions de novo and its factual determinations for substantial evidence. In re Am. Acad. Sci. Tech Ctr., 367 F.3d 1359, 1363 (Fed.Cir.2004). Substantial evidence means “such relevant evidence as a reasonable mind might accept as adequate to support a conclusion.” Consol. Edison Co. v. Nat’l Labor Relations Bd., 305 U.S. 197, 229, 59 S.Ct. 206, 83 L.Ed. 126 (1938).

Claim construction is a matter of law. Am. Acad. Sci. 367 F.3d at 1363. In contrast to district court proceedings involving an issued patent, claims under examination before the PTO are given their broadest reasonable interpretation consistent with the specification. In re ICON Health & Fitness, 496 F.3d 1374, 1379 (Fed.Cir.2007). That broader interpretive standard does not prejudice the applicant, who has the ability to correct errors in claim language and to adjust the scope of claim protection as needed during prosecution by amending the claims. In re Yamamoto, 740 F.2d 1569, 1571-72 (Fed.Cir.1984).

Anticipation is a question of fact, In re Suitco Surface, Inc., 603 F.3d 1255, 1259 *543 (Fed.Cir.2010), as is the issue of sufficient written description under § 112, ¶ 1, Ariad Pharms., Inc. v. Eli Lilly & Co.,

Free access — add to your briefcase to read the full text and ask questions with AI

In Re Taylor, 484 F. App'x 540 (Fed. Cir. 2012).

484 F. App'x 540 (In Re Taylor) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related